​
​

Regulus Therapeutics Ownership | Who Owns Regulus Therapeutics?

OverviewRevenueFinancialsChart

Regulus Therapeutics Ownership Summary

Regulus Therapeutics is owned by 85.07% institutional investors, 1.69% insiders, and 13.24% retail investors. Federated hermes is the largest institutional shareholder, holding 44.71% of RGLS shares. Federated Hermes Kaufmann R is the top mutual fund, with 12.04% of its assets in Regulus Therapeutics shares.

RGLS Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockRegulus Therapeutics85.07%1.69%13.24%
SectorHealthcare Stocks 47.25%8.01%44.75%
IndustryBiotech Stocks 45.35%7.81%46.83%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Federated Hermes Kaufmann R7.88M12.04%-
Federated Hermes Kaufmann Small Cap A7.42M11.33%-
Federated Hermes Kaufmann Small Cap Grow2.96M4.53%-450.00K
Federated Hermes Kaufmann Growth2.68M4.09%-505.00K
Vanguard Total Stock Mkt Idx Inv2.50M3.82%-
T. Rowe Price Health Sciences1.68M2.57%1.68M
iShares Russell 2000 ETF1.62M2.47%-3.64K
Victory Science & Technology1.54M2.34%126.95K
Vanguard Institutional Extnd Mkt Idx Tr1.13M1.73%-
Fidelity Small Cap Index644.44K0.98%-8.74K

Recent Insider Transactions

DateNameRoleActivityValue
Jul 25, 2024Collier Kathryn J-Buy$7.28K
Jan 18, 2024CALSADA CRISPINA Chief Financial OfficerSell$6.51K
Jan 18, 2024Aker Christopher Ray Sr. VP & General CounselSell$6.51K
Jan 18, 2024Hagan Joseph P Chief Executive OfficerSell$17.36K
Mar 01, 2022Drygin Denis Chief Scientific OfficerBuy$17.64K

Insider Transactions Trends

DateBuySell
2024 Q2--
2024 Q1-3
2023 Q3--
2023 Q2--
2023 Q1--

RGLS Ownership FAQ

Who Owns Regulus Therapeutics?

Regulus Therapeutics shareholders are primarily institutional investors at 85.07%, followed by 1.69% insiders and 13.24% retail investors. The average institutional ownership in Regulus Therapeutics's industry, Biotech Stocks , is 45.35%, which Regulus Therapeutics exceeds.

Who owns the most shares of Regulus Therapeutics?

Regulus Therapeutics’s largest shareholders are Federated hermes (12.85M shares, 44.71%), Vanguard group (4.05M shares, 14.09%), and Blackrock (3.97M shares, 13.81%). Together, they hold 72.61% of Regulus Therapeutics’s total shares outstanding.

Does Blackrock own Regulus Therapeutics?

Yes, BlackRock owns 13.81% of Regulus Therapeutics, totaling 3.97M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 7.08M$. In the last quarter, BlackRock increased its holdings by 3.9M shares, a 5733.89% change.

Who is Regulus Therapeutics’s biggest shareholder by percentage of total assets invested?

Octagon capital advisors lp is Regulus Therapeutics’s biggest shareholder by percentage of total assets invested, with 1.20% of its assets in 4.26M Regulus Therapeutics shares, valued at 7.61M$.

Who is the top mutual fund holder of Regulus Therapeutics shares?

Federated Hermes Kaufmann R is the top mutual fund holder of Regulus Therapeutics shares, with 12.04% of its total shares outstanding invested in 7.88M Regulus Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools